GERN
Geron CorporationNASDAQ
1d
5d
1m
6m
1y
5y
10y
Advanced Chart
  • LSS TRADING | Send Message 9 Nov
    Reply
      • Michael Blake Kuritz | Send Message 7 Nov

        janssen R&D is the head hancho of onco drugs...$GERN $TRIL $KURA
        Reply
          • Jonathan Faison | Send Message 3 Oct

            Near 52 Week Lows, Geron Is A Speculative Buy $GERN http://seekingalpha.com/a/2dxyc
            Reply
              • wilkinson99 | Send Message 3 Oct

                Premarket Top % Gainers: $XGTI 89%, $VHC 58%, $RELV 46%, $CGA 26%, $FVE 21%, $CAB 14% $WGO $NVFY $VVUS $JNS $DVAX $GERN $BAS $MGT $MSTX
                Reply
                  • LSS TRADING | Send Message 3 Oct
                    Reply
                      • wilkinson99 | Send Message 3 Oct

                        Premarket Top % Gainers: $RELV 131%, $XGTI 77%, $VHC 61%, $VVUS 26%, $FVE $NVFY $CAB $TPLM $DVAX $GERN $CTIC $BAS $WGO $AVXL $AMRS $UWTI
                        Reply
                          • wilkinson99 | Send Message 21 Sep

                            Top % Gainers: $VISN 20%, $CONN 17%, $MGT 17%, $NVAX 14%, $LINC 13%, $OVAS 13% $NADL $EBIO $NUGT $GALT $CLD $JNUG $IPI $VHC $HGT $SPSC $GERN
                            Reply
                              • MedTechBio | Send Message 19 Sep

                                As I Predicted, Cash Rich Geron Optimizes Dosage In Myelofibrosis Trial $GERN http://seekingalpha.com/a/2dvx8
                                Reply
                                  • wilkinson99 | Send Message 19 Sep

                                    Premarket Top % Gainers: $ISLE 30%, $ETRM 26%, $BLOX 15%, $NBY 14%, $XGTI 12%, $NWBO 11%, $FATE, $PTIE $EVBG $NVAX $ALDW $ESEA $IMNP $GERN
                                    Reply
                                      • Zach Hartman, PhD | Send Message 15 Sep

                                        Geron's Clinical Trial Update Paints An Uncertain Picture For Imetelstat: What To Expect $GERN http://seekingalpha.com/a/2dvgt
                                        Reply